The genetic nature of testicular germ cell tumors and the molecular mechanisms underlying the morphological and clinical dierences between the two subtypes, seminomas and nonseminomas, remains unclear. Genetic studies show that both subtypes exhibit many of the same regional genomic disruptions, although the frequencies vary and few clear dierences are found. We demonstrate signi®cant epigenetic dierences between seminomas and nonseminomas by restriction landmark genomic scanning. Seminomas show almost no CpG island methylation, in contrast to nonseminomas that show CpG island methylation at a level similar to other solid tumors. We ®nd an average of 1.11% of CpG islands methylation in nonseminomas, but only 0.08% methylated in seminomas. Furthermore, we demonstrate that seminomas are more highly hypomethylated than nonseminomas throughout their genome. Since both subtypes are thought to arise from primordial germ cells, the epigenetic dierences seen between these subtypes may re¯ect the normal developmental switch in primordial germ cells from an undermethylated genome to a normally methylated genome. We discuss these ®ndings in relation to dierent developmental models for seminomatous and nonseminomatous testicular germ cell tumors.
Introduction
Testicular germ cell tumors (TGCTs) account for 95% of all testicular tumors. Although accounting for only two per cent of all cancers in males, they are the most common cancers found in young men. These tumors arise from the primordial germ cells (PGCs). The unique biology of the PGCs makes these tumors an interesting model system for the study of the transformation of a totipotent cell, and dierentiation (Chaganti and Houldsworth, 1998) .
TGCTs are divided into two main histological types, the seminomas (SE), which resemble the undierentiated germ cells and the nonseminomas (NS), which can resemble both embryonic and extra-embryonic tissues due to their ability to dierentiate down either pathway (Looijenga et al., 1998) . One of the most basic questions in the biology of TGCTs is how such dierent tumors can arise from the same cell type . Both SE and NS exhibit similar cytogenetic abnormalities, with isochromosome for the short arm of chromosome 12, i(12p), as the most common (Lutzker and Barnard, 1998) . The nature of the genomic dierences that might account for the phenotypic distinctions between SE and NS remain elusive (Murty and Chaganti, 1998) .
The importance of epigenetic factors in cancer development is well established with a major focus during recent years on DNA methylation. In cancer, the tight regulation of DNA methylation breaks down, and the distribution of methyl-cytosine changes. Generally, the heavy methylation found in the bulk chromatin is reduced, while the normally unmethylated CpG islands become hypermethylated (Baylin et al., 2001; Costello and Plass, 2001; Jones, 2001) . However, DNA methylation in TGCTs must be evaluated in the context of the PGCs from which the tumors arise. The PGCs are at a developmental stage where their genomes are highly under-methylated (Bestor, 1998; Davis et al., 1999; Looijenga et al., 1998; Rajpert-De Meyts et al., 1998; Trasler, 1998) .
A previous methylation study has shown that speci®c gene promoters are hypermethylated in NS, but not in SE (Peltomaki, 1991) . In addition, studies of the X chromosome have demonstrated little or no methylation in SE, and more methylation in NS, particularly in more highly dierentiated NS (Looijenga et al., 1997) . These data suggest that the degree of dierentiation of the cells in question may be related to the methylation status of the genome. In cancer biology this phenomenon may be unique to germ cell tumors since they arise from cells that, in their normal developmental pathway, switch from an under-methylated genome to a normally methylated genome.
Here we present a comprehensive analysis by restriction landmark genomic scanning (RLGS) of the methylation state of an average of over 1400 RLGS fragments representing CpG islands in both SE and NS. We found that SE and NS exhibit signi®cant epigenetic dierences. While NS exhibited variable degrees of CpG island hypermethylation similar to other tumor types studied Fruhwald et al., 2001; , all SE showed little or no hypermethylation. We further demonstrated that the SE are more extensively hypomethylated in their bulk chromatin than NS, and discuss our ®ndings in relation to various models of TGCT development.
Results

RLGS analysis of TGCTs
In agreement with previously published data (Ottesen et al., 1997; Summersgill et al., 1998) , we found similar patterns of DNA copy number changes in both SE and NS by comparative genomic hybridization analysis on eight of the 16 tumors used for RLGS (data not shown). RLGS analysis using the enzyme combination NotI/EcoRV/HinfI was performed on high molecular weight DNA obtained from nine nonseminomatous and seven seminomatous TGCTs and, where available, from normal testis tissue from the same patients. Normal testis tissue with no evidence of intra-tubular malignant germ cells upon H and E section examination was available for eight patients. RLGS pro®les were analysed as described in Materials and methods. We have previously demonstrated that for all RLGS fragment loss events tested thus far, loss correlates with methylation of the NotI site Smiraglia et al., 1999) . Table 1 shows the number and percentage of RLGS fragments methylated in each tumor. Figure 1a ,b shows representative portions of RLGS pro®les where normal testis is compared to either SE or NS. The degree of CpG island methylation (range of 0.5 to 3.0%; mean of 1.11%) found in the NS samples is similar to that seen in other cancers. However, the lack of CpG island methylation found in the SE samples (range of 0.00 ± 0.18%; mean of 0.08%) is striking and signi®cantly dierent than for NS (standard two-tailed t-test, P=0.003). Although in previous work we have found individual tumors that show no CpG island hypermethylation, this is the ®rst example of an entire subset of tumors nearly devoid of CpG island hypermethylation by RLGS.
RLGS fragment cloning and loci characteristics
Eighteen RLGS fragments methylated in NS were readily clonable using the previously described arrayed NotI/EcoRV library cloning technique (Smiraglia et al., 1999) . These clones were sequenced and submitted to BLAST searches and CpG island characteristic detection programs. The results are summarized in Table 2 . All 18 clones are located within CpG islands con®rming the strong bias of RLGS towards identifying CpG islands. Ten clones are located in the 5' ends of genes. Six clones were associated with genes, but were found in the middle or the 3' ends of the genes. No unique gene homology could be found in the immediate genomic region near two clones (4C42, 2C35).
In the cases where gene expression data is publicly available through the National Center for Biotechnology Information (NCBI), most of these genes are expressed in many dierent tissues, and thus are not tissue-speci®c genes. Since most of the genes methylated in NS are not tissue-speci®c, it is unlikely that the observed methylation is due to dierentiation speci®c dierences between embryonal/extra-embryonal tissues and normal adult tissue. Furthermore, if the methylation dierences between normal and tumor were based on dierentiation, NS would be expected to show less methylation dierences than SE because they are more similar to the adult tissue in terms of degree of dierentiation. However, since we observe the opposite, we conclude that the methylation in NS likely represents aberrant CpG island hypermethylation similar to that seen in other tumor types, and not dierentiation-speci®c methylation. In addition, the lack of hypermethylation in SE cannot be explained The number of RLGS fragments studied in each comparison varies depending on the quality of the DNA used to prepare the two pro®les compared. Only unambiguously comparable RLGS fragments were counted. simply by the lack of dierentiation since in other tumor types we regularly ®nd very poorly dierentiated tumors with substantial degrees of hypermethylation.
Southern blot analysis confirms RLGS results
Six cloned RLGS fragments (2C57, 2F41, 2G10, 3F2, 3F50, and 4D7) were used as hybridization probes in genomic Southern blot analysis on a total of eight NS and 12 SE ( Figure 1c , and data not shown). Figure 1c shows high-level methylation in two NS for 3F50, but virtually no methylation in two SE. For the 20 tumor DNAs tested by Southern blot with six RLGS fragment clones, the NS showed variable levels of methylation with some tumors showing nearly complete methylation, while the SE showed very low-level, or no methylation. The methylation detected by Southern blot was in complete concordance with that detected by RLGS. As signi®cant lymphocyte in®ltra-tion is a common morphological feature of SE, the low-level methylation seen in some SE cases may be related to the low level seen in PBL DNA (Figure 1c ). These Southern blot data for speci®c loci ®t with the genome-wide observations concerning CpG islands as indicated by RLGS.
Bulk chromatin of SE is highly hypomethylated
The preceding data have demonstrated that aberrant CpG island methylation typical of all tumors types we have previously studied, including NS, is lacking in SE. These observations raise the question of whether or not SE are generally de®cient in the methylation of their genomes. All tumor types have been shown to have lower 5mC levels than normal tissues. In a study of 5mC content in 62 tumors of 23 dierent types, a SE tumor was shown to have nearly twofold less 5mC than any of the other tumors (no NS were included) (Gama-Sosa et al., 1983). We asked whether or not SE used in our study have less 5mC than the NS.
CpG islands typically account for only *15% of CpG dinucleotides and are generally thought to be unmethylated in normal tissues (Ng and Bird, 1999) . To assess a larger sampling of the remaining 85%, which are generally highly methylated in normal tissues, we used a recently developed technique called the cytosine extension assay (Pogribny et al., 1999) , which was shown to be highly sensitive, and to have several advantages over the methyl acceptance assay. With this assay we measured the ratio of incorporation of [ 3 H]dCTP after HpaII digestion to incorporation after MspI digestion and the data are displayed as the mean of three replicate experiments in Figure 2 . The overall level of CCGG hypomethylation is signi®cantly higher in SE than in NS (Figure 2 ; standard two-tailed t-test, P=0.0015). The SE ratios range from 0.36 ± 0.49 with a mean of 0.43, while the NS range from 0.19 ± 0.31 with a mean of 0.26. Given the lymphocyte in®ltration common in SE it is likely that in a pure population of SE cells this eect would be even more dramatic. Therefore, these data support RLGS and Southern blot data suggesting that SE cells are de®cient in methylation of their genomes including both CpG islands and bulk chromatin.
Discussion
Despite their genetic similarities, we have demonstrated a remarkable epigenetic dierence between SE and NS by RLGS analysis, and con®rmed this dierence by All genomic DNAs were digested with NotI and EcoRV, except for the left most lane which was digested with only EcoRV. Lanes are labeled with the tissue the DNA is from and the patient number. The blots were probed with a portion of the NotI/EcoRV RLGS fragment 3F50. The high molecular weight band is indicative of the EcoRV fragment uncut by NotI due to methylation of the NotI site. The low molecular band is indicative of the EcoRV fragment cut by NotI due to a lack of methylation of the NotI site. NT, normal testis; SE, seminoma; NS, nonseminoma; PBL, peripheral blood lymphocytes (non-cancer donor)
Oncogene CpG island methylation in TGCTs DJ Smiraglia et al As previously reported . BRE=breast carcinoma; CLN=colon carcinoma; GLI=glioblastoma; HN=head and neck squamous cell carcinoma; LEU=acute myeloid leukemia; PNET=meduloblastoma. c ND=not determined. Certain RLGS fragments were not previously reported due to polymorphism within the 98 samples Southern blot analysis. While NS show variable levels of RLGS fragment hypermethylation typical of other tumor types previously studied, the SE are unique in their lack of RLGS fragment hypermethylation. Furthermore, the epigenetic dierence seen at CpG islands has been demonstrated to also involve the bulk chromatin, with SE being more highly hypomethylated than NS despite the presence of contaminating lymphocyte DNA. One of the goals of genomic scanning for epigenetic changes is to be able to sub-classify tumor types based upon their overall epigenetic phenotypes, and ultimately to be able to describe distinct groups based on the combination of genetic and epigenetic abnormalities. Using a PCR based technique, Toyota et al. (1999) have identi®ed two sub-classi®cations of colorectal tumors based upon CpG island methylator phenotypes (CIMP). CIMP+ tumors were de®ned as exhibiting methylation in 3/7 or more markers whose methylation is speci®c to cancer, while CIMP7 tumors exhibited methylation in 1/7 or less (Toyota et al., 1999) . However, the lack of methylator phenotype in CIMP7 colorectal tumors is dierent than that for the SE described here. The CIMP7 colorectal tumors do show methylation of loci that is related to age (73% of the loci tested) (Toyota et al., 1999) , while the SE show nearly no RLGS fragment methylation. Furthermore, genetic alterations of the p53 and K-RAS genes segregated dierently between CIMP+ and CIMP7 colorectal tumors (Toyota et al., 2000) , but SE and NS exhibit no such genetic distinctions. Thus, the lack of hypermethylator phenotype in SE is distinct from the CIMP7 phenotype in colorectal cancer.
TGCTs arise from the primordial germ cells. While other tumor types may arise from stem cell populations, the primordial germ cells are unique in that they are at a critical developmental stage where the DNA methylation status of the genome is in¯ux. Similar to the pre-implementation embryo, PGCs are nearly devoid of DNA methylation. In mouse, multiple lines of evidence have shown that even after migration to the genital ridge at day 11.5, the PGC genome remains hypomethylated through day 16, but the euchromatin becomes heavily methylated by day 17 (Cogny et al., 1999; Davis et al., 1999) . The timing of this change from an under-methylated genome to a heavily methylated genome is within the same time frame where carcinoma in situ (CIS) is thought to develop from the PGCs .
Two popular models are currently debated in the literature concerning the development of SE and NS from CIS. The linear progression model proposes that SE is a step along the pathway to development of NS (Faulkner et al., 2000; Oosterhuis et al., 1989; Rorth et al., 2000) . The independent progression model proposes that CIS can independently give rise to both SE and NS (Rajpert-De Meyts et al., 1996 Rorth et al., 2000) . The ®rst model is based upon morphological and cytogenetic data. Morphologically, CIS appear very similar to SE and distinct from NS. Cytogenetically, CIS are hypertriploid to hypotetraploid, while SE are hypertriploid, and NS are hyperdiploid (Oosterhuis et al., 1989; Rorth et al., 2000) . The evidence for independent progression from CIS to either SE or NS comes from the identi®cation of heterogeneity within CIS. CIS associated with SE has dierent molecular markers than CIS found adjacent to NS. Numeric dierences have been identi®ed for chromosomes 12 and 15 (Looijenga et al., 1993) . In addition, the immunohistochemical marker TRA-1-60 is often found in CIS associated with NS, but not in CIS associated with SE (Rajpert-De Meyts et al., 1996) . Strong evidence supports both models and it is likely that both pathways exist. Combinations of both models have been postulated (Looijenga et al., 1998; RajpertDe Meyts et al., 1996) .
We have shown that SE have extremely low levels of CpG island hypermethylation and that their genomes are even more hypomethylated than NS. On the other hand, NS exhibit DNA methylation that is similar to other cancers of somatic cell origin. Our interpretation of these data ®ts best with the mixed model of tumor progression proposed by Rajpert-De Meyts et al. (1996) that allows for independent progression of SE and NS from CIS, along with linear progression (Rajpert-De Meyts et al., 1996) . In Figure 3 we incorporate our epigenetic observations into this mixed model and explain the development of the dierential epigenetic phenotypes based upon the timing of the transformation event(s) relative to the timing of the PGCs switch from an under-methylated genome to a normally methylated genome. Transformation events occurring prior to the switch in the methylation state of the PGC genome would create a CIS with low level TRA-1-60 expression and high copy number of chromosomes 12 and 15. This CIS-SE would eventually develop into a SE showing a highly hypomethylated genome with no aberrant CpG island hypermethylation. However, transformation events occurring after Figure 2 Histographic representation of the cytosine extension assay data. The data are presented as the ratio of the tritium incorporation after HpaII digestion of the genomic DNA to the incorporation after MspI digestion. Presented are the means of the three replicates and the error bars represent one s.d. of the mean. The height of the histogram bars indicates the relative degree of hypomethylation of the HpaII sites for each sample the switch to a methylated PGC genome would create a CIS with high level TRA-1-60 expression (due to the transformed cell being more dierentiated) and lower copy number of chromosomes 12 and 15. This CIS-NS would eventually develop into a NS with an epigenetic phenotype typical of other cancers. In the linear aspect of this model, tumors that are able to continue development from SE on to NS (as well as CIS-SE on to CIS-NS) may also have the ability to continue the development of DNA methylation similar to normal PGC development. Mixed germ cell tumors might arise from dierent subpopulations of cells progressing through the dierent pathways.
Thus, the timing of the transformation in relation to the degree of dierentiation of the PGCs may be a critical factor in determining the genetic and epigenetic phenotype of the CIS, and ultimately the tumor. The concept that the phenotypic dierences in CIS might be explained by the dierentiation state of the germ cell at the time of transformation has previously been proposed . The epigenetic dierences described here between SE and NS ®t well within this concept and support the model described above. Nevertheless, our evidence is indirect; looking at the epigenetic phenotypes of the endpoints ± the tumors ± compared to the progenitor cells. Measuring the epigenetic phenotypes of CIS associated with SE as compared to CIS associated with NS will help to provide more direct evidence supporting or denying this hypothesis.
It remains unclear if the morphological and clinical distinctions between SE and NS can be explained by the epigenetic dierences described here, or if these dierences are simply another phenotypic consequence of whatever factors determine whether a patient develops SE or NS. It seems that SE may be the result of over proliferation of PGCs that have lost their stem cell characteristics ), yet not correctly dierentiated to spermatocytes. NS may be the result of proliferation of PGCs that have retained their stem cell characteristics . It is clear that properly regulated genome methylation is required for normal development, and so perhaps the inability of CIS-SE cells to properly regulate the methylation of their genomes precludes the cells' ability to dierentiate. Conversely, perhaps the ability of CIS-NS to methylate their genome allows them to dierentiate, although incorrectly, and the aberrant methylation seen in the tumors is a result of the same type of dysregulation of the DNA methylation system commonly observed in other cancers. Whether or not the targets of promoter hypermethylation in NS play a role in the phenotypic dierences between SE and NS has not been addressed here and will require detailed analysis of these targets and the transcriptional consequences of their hypermethylation.
Materials and methods
Tissues
TGCTs were collected after surgical resection and the classi®cation of the tumors was done according to the WHO's recommendations. In cases where normal testis was available hematoxylin and eosin stained sections were evaluated and found to contain only normal testis tissue. We cannot rule out inclusion of intra-tubular malignant germ cells from other parts of the sample, however, such contamination with malignant cells is unlikely to aect RLGS analysis unless they become the majority cellular component of the normal tissue sample. Histological examination of the tumor samples was performed on frozen sections neighboring the tissue used for DNA extraction. Patients 5 and 12 were found to be mixed germ cell tumors. Patient 5 was a mixture of nonseminoma/seminoma and we analysed only the seminoma component. Patient 12 was a mixture of immature teratoma/seminoma and we analysed only the teratoma component. The institutional review board of The Ohio State University approved all procedures using human tissue. Samples from patients, 1, 2, 3, 4, 5, 7, 8, 12, 13, 21, 22 , and 24 were obtained from the Norwegian Radium Hospital. Samples from patients 9, 10, P9, P36, P41, P61, P66, P70, P75, P85, P89, and P94 were obtained from the University of Helsinki . Samples from patients 11, 14, and 15 were obtained at The Ohio State Figure 3 Proposed model explaining the development of SE and NS from CIS in relation to the methylation status of the PGC genome University through the Cooperative Human Tissue Network. Peripheral blood lymphocytes (PBLs) were obtained from a healthy 25-year-old Caucasian male collected at The Ohio State University.
RLGS
RLGS was performed as previously described . For each patient set, the normal testis pro®le was compared to the primary tumor pro®le. In each comparison, RLGS fragments present in the normal pro®le and absent or reduced in intensity by 30 ± 40% or greater (visual inspection) in the tumor pro®le from the same patient were scored as methylation events. We have previously determined by comparing quantitative Southern blot analysis with RLGS pro®le analysis, that we can reliably detect loss of spot intensity equal to 30 ± 40% methylation, depending on DNA quality. Normal testis DNA was not available for patient 10. In this case, the tumor pro®le was compared against his own PBL pro®le. In eight other cases where normal DNA was not available from the same patient, the tumor pro®le was compared to four normal pro®les from other patients. In order to reduce the possibility of counting genomic polymorphism as a methylation event, only RLGS fragments present in all four normal pro®les but absent from the tumor pro®le were scored as methylation events. Lymphocyte contamination in SE is of minimal concern in RLGS analysis since we were able to detect 30 ± 40% methylation. Even in samples with 50% lymphocyte in®ltration (possibly unmethylated DNA) we were still able to detect the methylated tumor DNA by RLGS. RLGS fragments were identi®ed by a coordinate naming system previously described by .
RLGS fragment cloning and characterization
RLGS fragments were cloned using the NotI/EcoRV boundary library mixing gels (Smiraglia et al., 1999) . Single pass sequencing was performed from the NotI end of the clone and used for database searches at NCBI. CpG island characteristics were determined using a CpG island prediction tool at the WebGene web site (http://www.itba.mi.cnr.it/ webgene/). All sequencing was performed at the Genotyping and Sequencing Unit at The Ohio State University, Division of Human Cancer Genetics.
Southern blots
Southern blot analysis was performed using standard techniques (Smiraglia et al., 1999) .
Cytosine extension assay
To assess levels of methylation at CCGG sites throughout the genome, the cytosine extension assay was performed (Pogribny et al., 1999) with slight modi®cations. Five hundred ng of genomic DNA from each sample was digested in a volume of 10 ml either with HpaII, MspI, or mock digested (500 ng each) using the appropriate digestion buer and 10 U of enzyme at 378C for 12 h. After digestion, the cytosine extension reaction was carried out and incorporation of [ 3 H]dCTP was measured. The counts from the mock digestion were considered the background for that DNA sample and were subtracted from the counts from both the HpaII digested DNA and the MspI digested DNA. In order to normalize the data for consistent amounts of starting material, for each sample, the ratio was taken between the HpaII counts and the MspI counts. The experiment was performed in triplicate for each sample, and the data is presented as the mean ratio (after background corrections). The error bars in Figure 2 represent one standard deviation of the mean.
